Mapping the Healthcare Pathway to Multidisciplinary Assessment of 12-25 Year Olds With Somatic Symptom Disorder

NCT ID: NCT06582173

Last Updated: 2025-09-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

36 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-10-31

Study Completion Date

2027-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to describe the course of successive care events that follow individuals with somatic symptom disorder until they are assessed by a specialized multidisciplinary team. Data is collected during interviews with subjects aged 12 to 25 years old accompanied by their parents. A biographical grid is used to retrospectively identify all care events that occurred from first symptoms until multidisciplinary assessment. Life events and symptoms are collected as well to explore how history of healthcare consumption is linked to other trajectories. A qualitative analysis of the recorded interviews aims to describe the subjective experience of this healthcare pathway.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Somatic symptom disorders (SSD), previously labelled Somatoform disorders, are known to challenge healthcare professionals and systems, as those common conditions reducing quality of life often lead to excessive referrals and investigations before adequate diagnosis and management. Although studies have proved multiple interventions to be effective and cost-effective in various clinical settings, little is known about the accurate healthcare utilization associated with SSD. Such analysis faces the complexity of SSD detection and labelling due to heterogeneous clinical presentations and disputed cross-disciplinary classifications. Even though healthcare is known to be a core theme of patient experience of SSD, the investigators lack data describing the trajectory of care and the expectations, perceived help and triggering events associated with healthcare services use. A better understanding of the healthcare pathway those patients follow will help implement evidence-based treatment effectively.

The aim of this study is to trace back the pathway of care that individuals follow before they eventually undergo a specialised multidisciplinary assessment.

This descriptive study relies on data retrospectively collected from patients and their parents during face-to-face interviews assisted by a biographical grid. Inclusion criteria for patients are to be aged 12 to 25 years old and to be diagnosed with SSD by a specialised multidisciplinary team. Variables measured to describe the healthcare pathway are chosen according to professional experience and literature review. They are collected alongside concomitant life events both to reduce memory bias and to explore determinants and effects of healthcare consumption as a secondary outcome. The subjective experience of this healthcare pathway described by patients and their parents is analysed qualitatively in the verbatim of the audio recorded interview.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Somatic Symptoms Medically Unexplained Symptoms Somatoform Disorders

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Adolescents

Patients aged 12 to 25 years old and diagnosed with SSD by a specialised multidisciplinary team

Face-to-face interviews assisted by a biographical grid

Intervention Type OTHER

Face-to-face interviews assisted by a biographical grid.

Healthcare event of the adolescent :

* medical specialist appointment
* general practitioner appointment
* emergency services use
* hospital admission
* diagnostic test
* medication use
* non-pharmacological treatment
* nursing or physical therapy
* alternative care

Biographical of the adolescent :

* Education event

* Class/level
* School
* Attendance
* Special arrangements
* Grades
* Off school education
* Family event

* Separation/union
* Birth/death
* Leave/Arrival
* Location/Moving
* Disease/accident
* Peer events

* Friendships
* Love interests
* Bullying
* Leisure \& interests events

* Activity
* Frequency

Parents

Parents of an adolescent included

Face-to-face interviews assisted by a biographical grid

Intervention Type OTHER

Face-to-face interviews assisted by a biographical grid.

Healthcare event of the adolescent :

* medical specialist appointment
* general practitioner appointment
* emergency services use
* hospital admission
* diagnostic test
* medication use
* non-pharmacological treatment
* nursing or physical therapy
* alternative care

Biographical of the adolescent :

* Education event

* Class/level
* School
* Attendance
* Special arrangements
* Grades
* Off school education
* Family event

* Separation/union
* Birth/death
* Leave/Arrival
* Location/Moving
* Disease/accident
* Peer events

* Friendships
* Love interests
* Bullying
* Leisure \& interests events

* Activity
* Frequency

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Face-to-face interviews assisted by a biographical grid

Face-to-face interviews assisted by a biographical grid.

Healthcare event of the adolescent :

* medical specialist appointment
* general practitioner appointment
* emergency services use
* hospital admission
* diagnostic test
* medication use
* non-pharmacological treatment
* nursing or physical therapy
* alternative care

Biographical of the adolescent :

* Education event

* Class/level
* School
* Attendance
* Special arrangements
* Grades
* Off school education
* Family event

* Separation/union
* Birth/death
* Leave/Arrival
* Location/Moving
* Disease/accident
* Peer events

* Friendships
* Love interests
* Bullying
* Leisure \& interests events

* Activity
* Frequency

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Criteria relating to the population studied:

* Age between 12 and 25 years old
* Diagnosis of somatic symptom disorder and derivatives (DSM 5) after specialized multidisciplinary evaluation by the team of the Maison des Adolescents of Cochin hospital (Maison de Solenn).

Criteria relating to the additional population participating in the research:

\- Being a parent of a subject who has received the diagnosis of somatic symptom disorder and derivatives (DSM 5) after specialized multidisciplinary evaluation at the Maison des Adolescents of Cochin Hospital (Maison de Solenn).

Exclusion Criteria

Criteria relating to the population studied:

* Age less than 12 years or greater than 25 years at the time of assessment,
* Subject presenting ongoing psychiatric decompensation, that is to say a state of mental health breaking with their baseline state and requiring rapid care which does not allow a research interview to be carried out.

Criteria relating to the additional population participating in the research:

None
Minimum Eligible Age

12 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

URC-CIC Paris Descartes Necker Cochin

OTHER

Sponsor Role collaborator

Assistance Publique - Hôpitaux de Paris

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Maude LUDOT-GREGOIRE, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Maison des Adolescents - Cochin Hospital - AP-HP

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Maison de Solenn Maison des Adolescents, Cochin Hospital

Paris, IDF, France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Maude LUDOT-GREGOIRE, MD, PhD

Role: CONTACT

+33 1 58 41 24 26

Marie BENHAMMANI-GODARD

Role: CONTACT

0033158411190

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Maude LUDOT-GREGOIRE, MD, PhD

Role: primary

+33 1 58 41 24 26

Pauline BOUE, MD

Role: backup

References

Explore related publications, articles, or registry entries linked to this study.

Joustra ML, Janssens KA, Bultmann U, Rosmalen JG. Functional limitations in functional somatic syndromes and well-defined medical diseases. Results from the general population cohort LifeLines. J Psychosom Res. 2015 Aug;79(2):94-9. doi: 10.1016/j.jpsychores.2015.05.004. Epub 2015 May 16.

Reference Type BACKGROUND
PMID: 26026696 (View on PubMed)

van Dessel N, den Boeft M, van der Wouden JC, Kleinstauber M, Leone SS, Terluin B, Numans ME, van der Horst HE, van Marwijk H. Non-pharmacological interventions for somatoform disorders and medically unexplained physical symptoms (MUPS) in adults. Cochrane Database Syst Rev. 2014 Nov 1;2014(11):CD011142. doi: 10.1002/14651858.CD011142.pub2.

Reference Type BACKGROUND
PMID: 25362239 (View on PubMed)

Wortman MSH, Lokkerbol J, van der Wouden JC, Visser B, van der Horst HE, Olde Hartman TC. Cost-effectiveness of interventions for medically unexplained symptoms: A systematic review. PLoS One. 2018 Oct 15;13(10):e0205278. doi: 10.1371/journal.pone.0205278. eCollection 2018.

Reference Type BACKGROUND
PMID: 30321193 (View on PubMed)

Gosselin A, Desgrees du Lou A, Lelievre E; PARCOURS Study Group. How to use sequence analysis for life course epidemiology? An example on HIV-positive Sub-Saharan migrants in France. J Epidemiol Community Health. 2018 Jun;72(6):507-512. doi: 10.1136/jech-2017-209739. Epub 2018 Feb 2.

Reference Type BACKGROUND
PMID: 29437866 (View on PubMed)

Sawyer SM, Azzopardi PS, Wickremarathne D, Patton GC. The age of adolescence. Lancet Child Adolesc Health. 2018 Mar;2(3):223-228. doi: 10.1016/S2352-4642(18)30022-1. Epub 2018 Jan 30.

Reference Type BACKGROUND
PMID: 30169257 (View on PubMed)

Kachaner A, Harim M, Combier A, Trouvin AP, Avouac J, Ranque B, Piot MA. Management perspectives from patients with fibromyalgia experiences with the healthcare pathway: a qualitative study. Front Med (Lausanne). 2023 Dec 1;10:1231951. doi: 10.3389/fmed.2023.1231951. eCollection 2023.

Reference Type BACKGROUND
PMID: 38105901 (View on PubMed)

Hinton D, Kirk S. Families' and healthcare professionals' perceptions of healthcare services for children and young people with medically unexplained symptoms: a narrative review of the literature. Health Soc Care Community. 2016 Jan;24(1):12-26. doi: 10.1111/hsc.12184. Epub 2015 Feb 16.

Reference Type BACKGROUND
PMID: 25684117 (View on PubMed)

Ludot M, Merlo M, Ibrahim N, Piot MA, Lefevre H, Carles ME, Harf A, Moro MR. ["Somatic symptom disorders" in adolescence. A systematic review of the recent literature]. Encephale. 2021 Dec;47(6):596-604. doi: 10.1016/j.encep.2021.04.007. Epub 2021 Sep 16. French.

Reference Type BACKGROUND
PMID: 34538623 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2024-A01371-46

Identifier Type: OTHER

Identifier Source: secondary_id

APHP240890

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.